$BDSI

Biodelivery Sciences International

  • NASDAQ
  • Health Technology
  • Pharmaceuticals: Other
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing

PRICE

$5.6 ▲0.179%

Extented Hours

VOLUME

2,107,479

DAY RANGE

5.59 - 5.6

52 WEEK

0 - 5.6

Join Discuss about BDSI with like-minded investors

profile
@dros #droscrew
recently

Increasing unusual call volume: $FRSH $BDSI $SB $TAK $GSM $TCOM Increasing unusual put volume: $TIP $WEBR $TGTX $ITUB $MNMD $MCHI $ZI $EWG

126 Replies 14 👍 12 🔥

profile
@dros #droscrew
recently

Downgrades 11/4: $ALL $AMC $AMRC $AON $ASAN $ATVI $AWk $BDSI $BIG $CLR $ELF $EQIX $GTHX $IPGP $OKE $PRG $QCOM $QRVO $RMNI $ROG $SBUX $SPXC $TRQ $UPLD $Z $ZG

42 Replies 13 👍 7 🔥

profile
@dros #droscrew
recently

$BDSI 18DEC20 $5 Cs // 4.5k+ trading vs 397 OI

97 Replies 7 👍 9 🔥

profile
@dros #droscrew
recently

$BDSI 18DEC20 $5 Cs // 4.5k+ trading vs 397 OI

109 Replies 12 👍 9 🔥

Key Metrics

Market Cap

0

Beta

0

Avg. Volume

0

Shares Outstanding

103.23 M

Yield

0%

Public Float

0

Next Earnings Date

Next Dividend Date

Company Information

BioDelivery Sciences International, Inc. is a commercial-stage specialty pharmaceutical company dedicated to patients living with chronic conditions. BDSI has built a portfolio of products that includes utilizing its novel and proprietary BioErodible MucoAdhesive (BEMA®) technology to develop and commercialize, either on its own or in partnership with third parties, new applications of proven therapies aimed at addressing important unmet medical needs. BDSI's marketed products address serious and debilitating conditions, including chronic pain and opioid-induced constipation.

CEO: Jeffrey Bailey

Website:

HQ: 4131 Parklake Ave Ste 225 Raleigh, 27612-2390 North Carolina

Related News